| Wiki Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Investing > A Day In The Life Of A Trader |
|
Wiki Articles - A Day In The Life Of A Trader
You’ve decided to get started as a trader or investor, but where do you start? The answer as always is very simple and the process I will take you through applies to virtually all markets (particularly shares, stocks and derivatives of these i.e. options and spread betting) Once you move into other markets (currency for example) you would have a different set of data and charts. One important According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product point to note, is that those of you who have full time employment and are just doing this for longer term investment, or to build up experience, all of the following can be done in the evenings or at the weekend. You may remember that I have said before, you do not need live data to start with - end of day data is fine. You also do not have to be sitting in front of your screen day after day, ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in in fact it is better if you do not - you will only become stressed! OK, I am going to assume that you are going to be trading shares/stocks/options or spread betting, depending on your experience. I suggest that you would follow the steps below, to arrive at a short list of prospects In the evening or overnight, you would download all the daily data, and your charts would be updated to show lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. the price action for that particular day. If you are trading the US markets then the data would probably have to be downloaded the following day as the markets only close at 9.00 pm UK time and update overnight. Now the general approach is called top down investing, because it is just that - we start with the big picture and work down! You would start by analysing the major indices for the ma here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ket you were considering. For the UK you would look at the FTSE100 index ( 250 and 350) , for the US the DJIA index etc. This will give you a view of the overall market, strength, weakness, support, resistance etc. Look at the daily volumes for unusual highs or lows. I would check the charts daily for volume anomalies. All shares and stocks are divided and sub divided into various industry an d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro market sectors. You need to analyse each industry sector chart, for strength and weakness, as well as support and resistance. After all, it makes sense - you do not want to be buying shares or stocks in a sector of the market which is particularly weak or selling short in a strong sector. (Most good charting packages will give you the facility to chart a share price with its performance again ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc st the market sector.) Naturally, there is no guarantee that any share you choose within a sector which is performing well will guarantee it will follow the trend, but it is a reasonable assumption to make as a start. Having identified what we feel are the stronger and weaker sectors, then we move on to look at the shares/stocks themselves. I would probably only check the sectors once a week. easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi Understanding and identifying industry and market sectors can be notoriously difficult. A good place to start is often the main exchange where details can usually be found - be aware that these do vary from country to country and exchange to exchange as there does not seem to be any standard in place at the moment. Having downloaded the end of day data, I would then check all my charts. As al nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ays, you would look for trends, volume, support and resistance, breakouts from a channel, turning points and candle patterns. You would also consider price movements on the day - the package I use offers the facility to set a filter which identifies shares which have moved up or down 2% on the day. A move this size might indicate a share that is active. Once you have identified a list of possi and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ble prospects, you would then compare them with their sector, to see whether they were in a good sector or not, and how they were performing relative to the sector. If they looked OK, you would add them to your watch list. Remember that an important part of money management is to diversify your portfolio - so please do not build your portfolio in one sector - this is another reason sector anal ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi sis is so important. In addition, you may think you know which sector a share or stock is in, but sometimes they can surprise you!! It is worth checking on any share or stock that you are considering as to details of any directors who have bought or sold shares recently. The software I use itemises recent deals which you can check. Please do not give any dealings too much weight as directors ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a re notorious for getting things wrong!! - they often buy in a vain attempt to support their share price, and could well be selling as share options become available or they have a divorce settlement to pay! If you see several senior directors selling heavily then this may be a signal that they know something that you do not! Check when a company is due to pay its dividends and the ex-dividend dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod date. If you buy a share one day before this date then you will be entitled to the dividend, but if you buy on the day you will not be entitled. There is a three day window between the ex-dividend date and the date of record. On the date of record all eligible shareholders are noted and these will be the people who receive the dividend. If you are not sure, check on the web site of the compan cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin - they should have an 'investor' section which will detail all past dividends, payment dates, history etc Again, check to see when the company is likely to be announcing its results. You do not want to buy the day before the company is due to announce its annual performance etc. ( you may consider this a good idea - that is fine - all I am saying is make the decision in the full knowledge of tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen all the facts ). Trading through announcements can be difficult. In the US it is particularly difficult as results are announced quarterly and almost as soon as one ' earning season' is finished, another one starts. In the UK it is not quite so bad, with results generally announced half-yearly or annually. On the broader front, keep an eye on the following : In the broad economy there are fou t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel r clear periods to the economic cycle. It is important that you try to recognise where you feel the country is economically. The four are, full recession, early recovery, full recovery and early recession. As the economy moves through this cycle which is repeated, various market sectors become more important and others less. The markets tend to lead the economic cycle. In early recovery indus ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust rial, basic industry and energy sectors tend to lead, in full recovery staples and service sectors tend to lead, in early recession utilities and finance sector stocks tend to lead, and finally in full recession cyclical and technology stocks tend to lead the way. Naturally these are only broad guidelines, but it is worth trying to establish where the economy is, at any one point, whilst you a y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products e trading. In trying to arrive at where you feel the economy may be, listen to the announcements on interest rates etc. You will almost certainly form your own view of the economy from your own experience of house prices, job opportunities, and retail knowledge. Try to use common sense rather than trying to acquire some deep knowledge of facts and figures that only economists understand. Afte . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de r all, if they know anything of value they would have retired long ago. Try to think in a common sense way. Keep a check on oil prices. This is not normally good news for the markets, as increased raw commodities such as oil, can only increase company’s costs and therefore reduce profitability. Despite this in the last 18 months with oil at record levels, shares have continued to move higher. elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip Keep an eye on the price of gold, because it can be an indicator of political uncertainty. It can also have a direct impact on mining stocks (look at oil prices recently) And finally, remember, you are in this to make money – not for fun. If you are looking for fun or a thrill, try the on line poker or horse racing. Trading and investing is hard work and is about making money – not losing it tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How To Save Your Business Money On Cleaning Supplies And Cleaning Services Contract Management Procedures
|